ChemoMetec A/S (CHEMM.CO)
Builds automated machines that count and analyze cells for research and manufacturing labs.
417.60+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-14.1%
The outlook
ChemoMetec trades at 417.6 with unanimous Strong Buy consensus from four analysts, whose average price target sits roughly 31% above the current level. The stock sits in the lower third of its 52-week range and shows mixed momentum relative to its moving averages, reflecting a bullish analyst view amid a relatively elevated valuation.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 4 analysts
Price trendMixed vs its moving averages
52-week range32% of the way from its 52-week low to high
Price targetAvg target +31% vs current price
Analyst price target
~12-month · 4 analysts546.25average target+30.8% vs now
Now 417.60
Low 450.00High 650.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$7.27B
52-wk high
804.00
52-wk low
235.20
50-day avg
379.96
200-day avg
503.81
Trailing P/E
41.0